Regulation 3 I1

United Kingdom

In section 128A (EU compulsory licences)—

F1(a)

in the heading for “EU compulsory”, substitute “Compulsory pharmaceutical”;

(b)

in subsection (1), for “an “EU compulsory”, substitute “a “compulsory pharmaceutical”;

(c)

in subsection (2)—

(i)

for “EU compulsory”, substitute “ compulsory pharmaceutical ”;

(ii)

“an EU compulsory”, substitute “a compulsory pharmaceutical”;

(d)

in subsection (5), for “an EU compulsory”, substitute “ a compulsory pharmaceutical ”.

Annotations

F1: Reg. 3(a)(b) substituted (31.12.2020 immediately before IP completion day) by The Intellectual Property (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1050), regs. 1(2), 27

I1: Reg. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1